Patients can text to enroll for information about the 30-day Free Trial Offer and $10 Co-pay programs
AVAILABLE TO ALL PATIENTS ‡
Regardless of insurance, patients can access a 30-day free trial offer,
pre-activated and ready to use when initiating treatment.
$10 CO-PAY OFFER FOR ELIGIBLE COMMERCIALLY INSURED PATIENTS
Eligible commercially insured patients may pay as little as $10 for up to a
90-day suppl y of ENTRESTO. §
† Limitations apply. See full Terms and Conditions below.
‡ Limitations apply. This voucher is good for a 30-day (maximum 60 tablets; one-time use) free trial of ENTRESTO at no cost for your patient. See full Terms and Conditions below.
§ Limitations apply. See Program Terms and Conditions. Eligible commercial patients pay as little as a $10 co-pay for each prescription fill (30-, 60-, 90-day fill) at retail or mail order. The program pays up to a $4100 cap across all fills per calendar year. Patient will be responsible for any co-pay once the $4100 limit is reached in a calendar year. This offer is not valid under Medicare, Medicaid, or any other federal or state program. See full Terms and Conditions below.
No purchase required. Submit claim to IQVIA using BIN #601341. This free trial is not health insurance. Void where prohibited by law. Product dispensed pursuant to terms and conditions of voucher. Claims shall not be submitted to any public or private third-party payer or any federal or state health care program for reimbursement. Valid only in the US and Puerto Rico. Offer not valid if reproduced or submitted to any other payer. It is illegal for any person to sell, purchase, or trade, or offer to sell, purchase, or trade, or to counterfeit the voucher. This is the property of Novartis Pharmaceuticals Corporation and must be returned upon request. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend offer without notice.
CO-PAY TERMS AND CONDITIONS
Limitations apply. Valid only for those with private insurance. The Program includes the co-pay offer, Payment Card (if applicable), and Rebate, with a combined annual limit of $4,100. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. Limitations may apply in CA and MA. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice. Some health plans might not accept a co-pay offer. Please contact your insurance provider to find out if your plan allows the use of co-pay offers.
The ENSPIRE Program from ENTRESTO ® , a free 12-month lifestyle and treatment support program, is designed to help your patients lead a healthier life. ENSPIRE provides them with a range of support resources and more:
NPAF, a nonprofit organization, is committed to providing access to Novartis medications for those most in need. If your patient is experiencing financial hardship, has limited or no prescription coverage, and cannot afford the cost of their medications, then they may be eligible to receive Novartis medications for free. To learn more, call 1-800-277-2254 or visit www.PAP.Novartis.com .
*In PARAGON-HF, defined as LVEF ≥45% with structural heart disease (LAE or LVH); median LVEF was 57%. LVEF is a variable measure and the normal range can vary. 2
Important Safety InformationBOXED WARNING: FETAL TOXICITY
ENTRESTO is contraindicated in patients with hypersensitivity to any component.
IndicationENTRESTO is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal.
LVEF is a variable measure, so use clinical judgment in deciding whom to treat.